Abstract:OBJECTIVES:The expression level of Ubiquitin-conjugating enzyme E2T (UBE2T) is upregulated in various types of human tumors. We explored the correlation and regulatory mechanism of UBE2T in the development of colorectal cancer (CRC).METHODS:Quantitative reverse transcription-polymerase chain reaction (qRT-PCR) was used to examine the expression of UBE2T in the CRC tissues and cell lines. Immunohistochemical staining, spearman correlation analysis, and Kaplan Meier-survival analysis were used to demonstrate the correlation between UBE2T high expression level and the clinical characteristics of malignant patients and the overall survival. The proliferation, apoptosis, migration and invasion of CRC cells were analyzed by cell transfection, MTT, colony formation, scratch assay, transwell, and flow cytometry. Furthermore, the expression of cell proliferation and apoptosis related proteins and ubiquitination of p53 were detected by western blot.RESULTS:UBE2T was up-regulated in CRC tissues and cell lines, and high expression level of UBE2T was correlated with the clinical characteristics of malignant of CRC patients (P<0.05), and patients with high expression level of UBE2T had lower overall survival (P=0.0455). In addition, UBE2T could promote the growth, proliferation, invasion and metastasis of CRC cells and inhibit the apoptosis. At the same time, knockdown of UBE2T inhibited the growth of transplanted tumor in mice of subcutaneous CRC model. Moreover, our experimental results proved that UBE2T regulated the expression of downstream related proteins through ubiquitination of p53 protein to promote the occurrence and development of CRC.CONCLUSION:Our study elucidated that high expression of UBE2T would enhance the development of CRC, and then further explored its molecular mechanism both in vitro and in vivo. The results indicated that UBE2T facilitated ubiquitination and degradation of p53, which predicts the possibility of UBE2T as one of molecular diagnosis markers, prognostic indicators and therapeutic drug targets of CRC patients.

UBTD1 Induces Cellular Senescence Through an UBTD1-Mdm2/p53 Positive Feedback Loop.

HBP1-mediated Regulation of P21 Protein Through the Mdm2/p53 and TCF4/EZH2 Pathways and Its Impact on Cell Senescence and Tumorigenesis

PDCD5 Interacts with P53 and Functions As a Positive Regulator in the P53 Pathway.

Inhibition of DYRK1A-EGFR axis by p53-MDM2 cascade mediates the induction of cellular senescence

Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis

Mdm2 links genotoxic stress and metabolism to p53

MTA1 Coregulator Regulates P53 Stability and Function

Escape, or Vanish: Control the Fate of p53 through MDM2-Mediated Ubiquitination.

Of the many cellular responses activated by TP53, which ones are critical for tumour suppression?

DEC1, a basic helix-loop-helix transcription factor and a novel target gene of the p53 family, mediates p53-dependent premature senescence.

Stabilization of Mdm2 Via Decreased Ubiquitination is Mediated by Protein Kinase B/Akt-dependent Phosphorylation

Cell-cycle arrest and senescence in TP53-wild type renal carcinoma by enhancer RNA-P53-bound enhancer regions 2 (p53BER2) in a p53-dependent pathway

Microrna-1827 Represses MDM2 to Positively Regulate Tumor Suppressor P53 and Suppress Tumorigenesis

USP10 Regulates p53 Localization and Stability by Deubiquitinating p53

Dusp1 is Controlled by P53 During the Cellular Response to Oxidative Stress

Ubiquitin-conjugating Enzyme E2T(UBE2T) Promotes Colorectal Cancer Progression by Facilitating Ubiquitination and Degradation of P53.

UFMylation maintains tumour suppressor p53 stability by antagonizing its ubiquitination

USP49 participates in the DNA damage response by forming a positive feedback loop with p53

USP11 modulates mitotic progression and senescence by regulating the p53-p21 axis through MDM2 deubiquitination

Insulin Receptor Tyrosine Kinase Substrate Enhances Low Levels Of Mdm2-Mediated P53 Ubiquitination

Inhibitory Effect of Bcl-2 on P53-Mediated Transactivation Following Genotoxic Stress